Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Chagas Disease Unfamiliar to Many U.S. Physicians

By LabMedica International staff writers
Posted on 26 Oct 2010
Chagas disease manifests both as an acute or chronic disease, caused by the parasitic protozoa Trypanosoma cruzi and should no longer be thought of as exotic. More...


The diagnosis of Chagas disease can be made by observation of the parasite in a blood smear by microscopic examination. A thick and thin blood smear are made and stained for visualization of parasites. However, a blood smear works well only in the acute phase of infection when parasites are seen circulating in blood. For screening blood donated for transfusion, antibody detection tests are available.

The disease is spread by infected insects called triatomine bugs and is only transmitted on the American continents. Infection can also occur through blood transfusions, ingestion of contaminated food or drink, organ transplants, and from an infected mother to her unborn child. For obstetricians and gynecologists in the U.S., increased awareness around Chagas disease is important because many newly diagnosed patients are identified among blood donors who are women of childbearing age and at risk of transmitting the infection to their newborns. Although congenital Chagas disease is relatively rare in the US, the estimated 300 annual cases are similar to other rare diseases for which all newborns in the U.S. are routinely screened at birth.

A survey published in the October 2010 issue of the American Journal of Tropical Medicine and Hygiene, revealed that knowledge and understanding of this condition is low among obstetrician-gynecologists. The survey results found that only 3% of the physicians surveyed considered their knowledge about Chagas disease excellent or good compared to a large majority (88%) who described their knowledge as limited or very limited; almost 10% of those surveyed reported never having heard of the disease at all. One-third of survey respondents did not know what causes the disease, and only 58% were able to identify it correctly as a parasitic infection.

Jennifer R. Verani, M.D., from the Center for Disease Control and Prevention (CDC; Atlanta, GA; USA), said, "The good news about the survey results is that the majority of physicians respondents were not misinformed, they just did not have information about Chagas disease.” Edward T. Ryan, M.D., President of American Society of Tropical Medicine and Hygiene, added, "There are potentially 100,000 women living in the U.S. who are at risk of infecting their unborn babies. We need to educate obstetricians, family practitioners, nurse midwives, and pediatricians about Chagas, especially those who care for families from Latin America."

If left untreated, Chagas disease can cause complications such as cardiomyopathy, heart disease, heart failure, enlargement of the colon, enlargement of the esophagus and malnutrition. An estimated 20% to 30% of patients will develop the cardiovascular/digestive complications, decades after the initial infection.

Related Links:

CDC


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: iStock

Clinical Trial Evaluates Liquid Biopsy for Early-Stage Breast Cancer Detection

Breast cancer screening relies primarily on mammography, but abnormal findings can lead to additional imaging, biopsy, or repeat imaging after six months, creating anxiety and potentially delaying treatment... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: Latest trends show that cancer diagnosis is evolving beyond a process focused mainly on medical imaging and microscopic tissue examination toward a more layered approach that incorporates molecular and genomic testing, liquid biopsy, digital pathology, and AI (Image Credit: iStock)

Expanding Screening and Biomarker Testing Drive Cancer Diagnostics Market Growth

Cancer diagnostics encompasses imaging, tissue pathology, laboratory testing, and molecular technologies used to detect, confirm, characterize, and monitor cancer. The global cancer diagnostics market... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.